The Importance of Early Detection and the Management of Patients With Lung Cancer

October 18 from 1:45 pm 2:30 pm CDT

Supported By: AstraZeneca

Program Description

Dr Susan Garwood with HCA enterprises is presenting an informative program on the importance of early detection of lung cancer and the management of thoracic oncology patients. This presentation is intended to provide education on detecting early stages of lung cancer by LDCT and IPN follow-up programs and the best practices for maintaining lung cancer care post COVID-19 pandemic.

This is a non-CME event and does not qualify for CME, CE, or MOC credit. This event is not part of the official CHEST Annual Meeting 2022 conference sessions. This event is not endorsed by CHEST and does not reflect the views or opinions of CHEST.

Speakers

Susan Garwood, MD
HCA Enterprise
Physician Director, Pulmonary Services
Nashville, TN